Clinical Trials Directory

Trials / Completed

CompletedNCT01294033

Effect of Supplemental Oxygen on Maximal Oxygen Consumption in Patients With Chronic Obstructive Pulmonary Disease

Effect of Therapeutic Hyperoxia on Maximal Oxygen Consumption and Perioperative Risk Stratification in Patients With Chronic Obstructive Pulmonary Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Maximal consumption of oxygen (VO2max) during exercise is used in patients with chronic obstructive pulmonary disease (COPD) to stratify perioperative risk. However, the impact of supplemental oxygen to prevent hypoxemia during exercise on maximal oxygen consumption and other ventilatory parameters during maximal exercise in the resting normoxic Chronic Obstructive Pulmonary Disease population is poorly defined. The investigators performed a randomized controlled trial in patients with COPD who underwent cardiopulmonary exercise tests on room air and supplemental oxygen. The investigators compared maximal oxygen consumption and other ventilatory parameters in each individual subject under the two conditions.

Conditions

Interventions

TypeNameDescription
OTHERFractional inspired oxygen (FiO2) 0.21
OTHERFractional inspired oxygen 0.28Supplemental oxygen

Timeline

Start date
2009-08-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2011-02-11
Last updated
2017-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01294033. Inclusion in this directory is not an endorsement.